학술논문
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Document Type
Article
Author
Source
Subject
*COVID-19
*CONFIDENCE intervals
*COVID-19 vaccines
*IMMUNOCOMPROMISED patients
*AGE distribution
*DEXAMETHASONE
*ANTIVIRAL agents
*CANCER patients
*RISK assessment
*HEMATOLOGIC malignancies
*HOSPITAL care
*MESSENGER RNA
*CHI-squared test
*DESCRIPTIVE statistics
*RESEARCH funding
*VACCINATION status
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1444-0903
Abstract
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified. [ABSTRACT FROM AUTHOR]